ThePrint2 天
Cipla set to bring Afrezza, 1st inhalable insulin since Exubera, to Indian markets by 2025
Afrezza, world’s only rapid-acting, inhaled insulin for type 1 & type 2 diabetes patients & manufactured by MannKind, ...
Medscape17 天
Can Inhaled Insulin Be Used for the Treatment of Diabetes Mellitus?
The author has participated in a Phase II clinical trial with Technosphere insulin and received lecturing fees from Pfizer Inc. and NovoNordisk. The author has no other relevant affiliations or ...